Government’s $600M Contract With Troubled Emergent Vaccine Plant is No More

Following a year in which vaccine manufacturing plant Emergent BioSolutions spent many months in the headlines for botching 75 million Johnson & Johnson (J&J) COVID-19 vaccines, the federal government and the troubled company have parted ways.
Source: Drug GMP Report